20S proteasome — Drug Target

All drugs that target 20S proteasome — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Proteasome inhibitor

Phase 3 pipeline (2)

• TLK286 HCl for injection · Telik · Proteasome inhibitor · Oncology
  TLK286 HCl for injection is a proteasome inhibitor.
• VBMCP/VBAD/Velcade · PETHEMA Foundation · Proteasome inhibitor · Oncology
  Velcade works by inhibiting the proteasome, a complex within cells that breaks down proteins.

Phase 2 pipeline (2)

• Carfilzomib, proteasome inhibitor; intravenous · Pfizer · Proteasome inhibitor · Oncology
  Proteasome inhibitor
• Bortezomib, Rituximab, Dexamethasone · Meletios A. Dimopoulos · Proteasome inhibitor · Oncology
  Proteasome inhibitor